mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.7 |